IP Library Patent Application 10518184
Patent Application
App. No. 10/518,184

Preventives remedies for bone and joint diseases

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/518,184
Abstract

A compound or its salt that inhibits the activity of a protein having an amino acid sequence which is the same or substantially the same amino acid sequence represented by SEQ ID NO: 1, an antibody to the above protein, an antisense nucleotide having a base sequence which is complementary or substantially complementary to the base sequence of a DNA encoding the above protein or its peptide fragment, etc. are usable as prophylactic/therapeutic agents for bone and joint diseases.

Claims (18)

1 . A prophylactic/therapeutic agent for bone and joint diseases, comprising a compound or its salt that inhibits the activity of a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof.

2 . A prophylactic/therapeutic agent for bone and joint diseases, comprising a compound or its salt that inhibits the expression of a gene for a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof.

3 . A prophylactic/therapeutic agent for bone and joint diseases, comprising an antisense nucleotide having a base sequence which is complementary or substantially complementary to the base sequence of a polynucleotide encoding a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, or its partial peptide, or a part of the base sequence.

4 . A prophylactic/therapeutic agent for bone and joint diseases, comprising an antibody to a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof.

5 . The prophylactic/therapeutic agent according to claim 1 wherein the bone and joint diseases are chondrodysplasia, bone dysplasia, osteoporosis, osteoarthritis, chronic articular rheumatism, arthritis, synovitis, metabolic arthropathy or sports-related joint disorders.

6 . A diagnostic agent for bone and joint diseases, comprising an antibody to a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof.

7 . A diagnostic agent for bone and joint diseases, comprising a polynucleotide encoding a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, or its partial peptide.

8 . The diagnostic agent according to claim 6 , wherein the bone and joint diseases are chondrodysplasia, bone dysplasia, osteoporosis, osteoarthritis, chronic articular rheumatism, arthritis, synovitis, metabolic arthropathy or sports-related joint disorders.

9 . A prophylactic/therapeutic agent for bone and joint diseases, comprising a compound or its salt having an action of inhibiting a sulfatase activity.

10 . A prophylactic/therapeutic agent for bone and joint diseases, comprising a compound or its salt having an action of inhibiting the expression of a sulfatase.

11 . A method of screening a prophylactic/therapeutic agent for bone and joint diseases, which comprises using a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof.

12 . A kit for screening a prophylactic/therapeutic agent for bone and joint diseases, comprising a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof.

13 . A method of screening a prophylactic/therapeutic agent for bone and joint diseases, which comprises using a polynucleotide encoding a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, or its partial peptide.

14 . A kit for screening a prophylactic/therapeutic agent for bone and joint diseases, comprising a polynucleotide encoding a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, or its partial peptide.

15 . (canceled)

16 . A method of preventing/treating bone and joint diseases, which comprises administering to a mammal an effective dose of a compound or its salt that inhibits the activity of a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof, or an effective dose of a compound or its salt that inhibits the expression of a gene for the protein.

17 . A method of preventing/treating bone and joint diseases, which comprises inhibiting the activity of a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof, or inhibiting the expression of a gene for the protein.

18 . Use of a compound or its salt that inhibits the activity of a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, its partial peptide, or a salt thereof, or a compound or its salt that inhibits the expression of a gene for the protein, to manufacture a prophylactic/therapeutic agent for bone and joint diseases.

Assignments (2)
CHANGE OF NAME Recorded Jun 17, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016914/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2004
From: WATANABE, TATSUYA; INAZUKA, MASAKAZU
To: TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
Reel/Frame 017205/0708 →